Search

everythinglearnresearchcommunity

for

Search:↓

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Hormonal therapies are safe and effective for treating adult women's acne.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Finasteride shows promise for female hair loss, but more research needed.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

The document concludes that more research is needed to fully understand the causes of PCOS.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.